P

PT UBC Medical Indonesia Tbk
IDX:LABS

Watchlist Manager
PT UBC Medical Indonesia Tbk
IDX:LABS
Watchlist
Price: 139 IDR -0.71%
Market Cap: 549.1B IDR

Intrinsic Value

The intrinsic value of one LABS stock under the Base Case scenario is hidden IDR. Compared to the current market price of 139 IDR, PT UBC Medical Indonesia Tbk is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

LABS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
PT UBC Medical Indonesia Tbk

Intrinsic Value History
Dive into the past to invest in the future

LABS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LABS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about LABS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LABS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PT UBC Medical Indonesia Tbk.

Explain Valuation
Compare LABS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LABS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
PT UBC Medical Indonesia Tbk

Balance Sheet Decomposition
PT UBC Medical Indonesia Tbk

Current Assets 171.7B
Cash & Short-Term Investments 17.2B
Receivables 48.6B
Other Current Assets 105.8B
Non-Current Assets 37.5B
PP&E 27B
Intangibles 4.8B
Other Non-Current Assets 5.6B
Current Liabilities 56.9B
Accounts Payable 32.1B
Accrued Liabilities 254.7m
Short-Term Debt 22.4B
Other Current Liabilities 2.2B
Non-Current Liabilities 6.5B
Long-Term Debt 1.8B
Other Non-Current Liabilities 4.7B
Efficiency

Free Cash Flow Analysis
PT UBC Medical Indonesia Tbk

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PT UBC Medical Indonesia Tbk

Revenue
176.6B IDR
Cost of Revenue
-108.7B IDR
Gross Profit
67.9B IDR
Operating Expenses
-52.2B IDR
Operating Income
15.7B IDR
Other Expenses
-6.4B IDR
Net Income
9.3B IDR
Fundamental Scores

LABS Profitability Score
Profitability Due Diligence

PT UBC Medical Indonesia Tbk's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Low ROIC
Low Operating Margin
hidden
Profitability
Score

PT UBC Medical Indonesia Tbk's profitability score is hidden . The higher the profitability score, the more profitable the company is.

LABS Solvency Score
Solvency Due Diligence

PT UBC Medical Indonesia Tbk's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

PT UBC Medical Indonesia Tbk's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LABS Price Targets Summary
PT UBC Medical Indonesia Tbk

There are no price targets for LABS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

PT UBC Medical Indonesia Tbk
does not pay dividends
Shareholder Yield

Current shareholder yield for LABS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one LABS stock?

The intrinsic value of one LABS stock under the Base Case scenario is hidden IDR.

Is LABS stock undervalued or overvalued?

Compared to the current market price of 139 IDR, PT UBC Medical Indonesia Tbk is hidden .

Back to Top